Biodegradable gemcitabine-loaded microdevice with sustained local drug delivery and improved tumor recurrence inhibition abilities for postoperative pancreatic tumor treatment

References

• Abdelkader H, Fathalla Z, Seyfoddin A, et al. (2021). Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: inserts, patches, wafers, and implants. Adv Drug Deliv Rev 177:1595.
   Web of Science ®Google Scholar
• Anderson JM, Shive MS. (2012). Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 64:72–82.
   Web of Science ®Google Scholar
• Bastiancich C, Malfanti A, Preat V, et al. (2021). Rationally designed drug delivery systems for the local treatment of resected glioblastoma. Adv Drug Deliv Rev 177:113951.
   PubMed Web of Science ®Google Scholar
• Bode C, Kranz H, Fivez A, et al. (2019). Often neglected: PLGA/PLA swelling orchestrates drug release: HME implants. J Control Release 306:97–107.
   PubMed Web of Science ®Google Scholar
• Bourdillon P, Boissenot T, Goldwirt L, et al. (2018). Incomplete copolymer degradation of in situ chemotherapy. J Mater Sci Mater Med 29:25.
   PubMed Web of Science ®Google Scholar
• Cai H, Wang R, Guo X, et al. (2021). Combining gemcitabine-loaded macrophage-like nanoparticles and erlotinib for pancreatic cancer therapy. Mol Pharm 18:2495–506.
   PubMed Web of Science ®Google Scholar
• Chen H, Xie LQ, Qin J, et al. (2016). Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Colloids Surf B Biointerfaces 138:1–9.
   PubMed Web of Science ®Google Scholar
• Cheng L, Lei L, Guo S. (2010). In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends. Int J Pharm 387:129–38.
   PubMed Web of Science ®Google Scholar
• Chew SA, Danti S. (2017). Biomaterial-based implantable devices for cancer therapy. Adv Healthc Mater 6:1600766.
   Web of Science ®Google Scholar
• da Silva D, Kaduri M, Poley M, et al. (2018). Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems. Chem Eng J 340:9–14.
   PubMed Web of Science ®Google Scholar
• Dasanu CA. (2008). Gemcitabine: vascular toxicity and prothrombotic potential. Expert Opin Drug Saf 7:703–16.
   PubMed Web of Science ®Google Scholar
• De Dosso S, Siebenhüner AR, Winder T, et al. (2021). Treatment landscape of metastatic pancreatic cancer. Cancer Treat Rev 96:102180.
   PubMed Web of Science ®Google Scholar
• Du C, Qi Y, Zhang Y, et al. (2018). Epidermal growth factor receptor-targeting peptide nanoparticles simultaneously deliver gemcitabine and olaparib to treat pancreatic cancer with breast cancer 2 (BRCA2) mutation. ACS Nano 12:10785–96.
   PubMed Web of Science ®Google Scholar
• Ducreux M, Cuhna AS, Caramella C, et al. (2015). Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26:V56–V68.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. (2021). Cancer statistics for the year 2020: an overview. Int J Cancer 149:778–89.
   Web of Science ®Google Scholar
• Fleming AB, Saltzman WM. (2002). Pharmacokinetics of the carmustine implant. Clin Pharmacokinet 41:403–19.
   PubMed Web of Science ®Google Scholar
• Gao L, Xia LY, Zhang RH, et al. (2017a). Enhanced antitumor efficacy of poly(d,l-lactide-co-glycolide)-based methotrexate-loaded implants on sarcoma 180 tumor-bearing mice. Drug Des Devel Ther 11:3065–75.
   PubMed Web of Science ®Google Scholar
• Gao L, Xie C, Du Y, et al. (2017b). Characterization and antitumor efficacy of poly(l-lactic acid)-based etoposide-loaded implants. Drug Deliv 24:765–74.
   PubMed Web of Science ®Google Scholar
• Giannini E, Botta F, Fasoli A, et al. (1999). Progressive liver functional impairment is associated with an increase in AST ALT ratio. Dig Dis Sci 44:1249–53.
   PubMed Web of Science ®Google Scholar
• Gopferich A. (1997). Polymer bulk erosion. Macromolecules 30:2598–604.
   Web of Science ®Google Scholar
• He P, Xu S, Guo Z, et al. (2022). Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy. Drug Deliv 29:478–88.
   PubMed Web of Science ®Google Scholar
• Jelonek K, Kasperczyk J. (2013). Polyesters and polyester carbonates for controlled drug delivery. Polimery 58:654–62.
   Web of Science ®Google Scholar
• Kamisawa T, Wood LD, Itoi T, et al. (2016). Pancreatic cancer. Lancet 388:73–85.
   PubMed Web of Science ®Google Scholar
• Kim MS, Ahn HH, Shin YN, et al. (2007). An in vivo study of the host tissue response to subcutaneous implantation of PLGA- and/or porcine small intestinal submucosa-based scaffolds. Biomaterials 28:5137–43.
   PubMed Web of Science ®Google Scholar
• Kindler HL. (2018). A glimmer of hope for pancreatic cancer. N Engl J Med 379:2463–4.
   PubMed Web of Science ®Google Scholar
• Koerber M. (2010). PLGA erosion: solubility- or diffusion-controlled? Pharm Res 27:2414–20.
   PubMed Web of Science ®Google Scholar
• Krukiewicz K, Zak JK. (2016). Biomaterial-based regional chemotherapy: local anticancer drug delivery to enhance chemotherapy and minimize its side-effects. Mater Sci Eng C Mater Biol Appl 62:927–42.
   PubMed Web of Science ®Google Scholar
• Kulkarni A, Reiche J, Lendlein A. (2007). Hydrolytic degradation of poly(rac-lactide) and poly (rac-lactide)-co-glycolide at the air–water interface. Surf Interface Anal 39:740–6.
   Web of Science ®Google Scholar
• Laracuente ML, Yu MH, McHugh KJ. (2020). Zero-order drug delivery: state of the art and future prospects. J Control Release 327:834–56.
   PubMed Web of Science ®Google Scholar
• Li L, Li C, Zhou J. (2018). Effective sustained release of 5-FU-loaded PLGA implant for improving therapeutic index of 5-FU in colon tumor. Int J Pharm 550:380–7.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang HY, Lee DS. (2021). Advances in biodegradable and injectable hydrogels for biomedical applications. J Control Release 330:151–60.
   PubMed Web of Science ®Google Scholar
• Lin W, Xu T, Wang Z, et al. (2021). Sustained intrathecal delivery of amphotericin B using an injectable and biodegradable thermogel. Drug Deliv 28:499–509.
   PubMed Web of Science ®Google Scholar
• Liu W, Dong A, Wang B, et al. (2021). Current advances in black phosphorus-based drug delivery systems for cancer therapy. Adv Sci 8:2003033.
   Web of Science ®Google Scholar
• Lu J, Zheng L, Chen G, et al. (2020). Trend analysis and evaluation of quality of goserelin acetate sustained-release depot. Chin J Pharm Anal 40:971–81.
   Google Scholar
• Mao L, Wu W, Wang M, et al. (2021). Targeted treatment for osteoarthritis: drugs and delivery system. Drug Deliv 28:1861–76.
   PubMed Web of Science ®Google Scholar
• O'Reilly EM, Abou-Alfa GK. (2007). Cytotoxic therapy for advanced pancreatic adenocarcinoma. Semin Oncol 34:347–53.
   PubMed Web of Science ®Google Scholar
• Paniccia A, Hosokawa P, Henderson W, et al. (2015). Characteristics of 10-year survivors of pancreatic ductal adenocarcinoma. JAMA Surg 150:701–10.
   PubMed Web of Science ®Google Scholar
• Paroha S, Verma J, Dubey RD, et al. (2021). Recent advances and prospects in gemcitabine drug delivery systems. Int J Pharm 592:120043.
   PubMed Web of Science ®Google Scholar
• Pourshams A, Sepanlou SG, Ikuta KS, et al. (2019). The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 4:934–47.
   PubMed Web of Science ®Google Scholar
• Ramazani F, van Nostrum CF, Storm G, et al. (2016). Locoregional cancer therapy using polymer-based drug depots. Drug Discov Today 21:640–7.
   PubMed Web of Science ®Google Scholar
• Rivera-Hernandez G, Antunes-Ricardo M, Martinez-Morales P, et al. (2021). Polyvinyl alcohol based-drug delivery systems for cancer treatment. Int J Pharm 600:120478.
   PubMed Web of Science ®Google Scholar
• Sartor O. (2003). Eligard: leuprolide acetate in a novel sustained-release delivery system. Urology 61:25–31.
   PubMed Web of Science ®Google Scholar
• Shabana AM, Kambhampati SP, Hsia R-C, et al. (2021). Thermosensitive and biodegradable hydrogel encapsulating targeted nanoparticles for the sustained co-delivery of gemcitabine and paclitaxel to pancreatic cancer cells. Int J Pharm 593:120139.
   PubMed Web of Science ®Google Scholar
• Shen YY, Qin HW, Zhang JB, et al. (2016). Fluorouracil implants caused a diaphragmatic tumor to be misdiagnosed as liver metastasis: a case report. BMC Cancer 16:754.
   PubMed Web of Science ®Google Scholar
• Su Y, Zhang B, Sun R, et al. (2021). PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Deliv 28:1397–418.
   PubMed Web of Science ®Google Scholar
• Sugisawa N, Miyake K, Higuchi T, et al. (2019). Induction of metastasis by low-dose gemcitabine in a pancreatic cancer orthotopic mouse model: an opposite effect of chemotherapy. Anticancer Res 39:5339–44.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–49.
   PubMed Web of Science ®Google Scholar
• Talebian S, Foroughi J, Wade SJ, et al. (2018). Biopolymers for antitumor implantable drug delivery systems: recent advances and future outlook. Adv Mater 30:1706665.
   Web of Science ®Google Scholar
• Togawa A, Ito H, Kimura F, et al. (2003). Establishment of gemcitabine-resistant human pancreatic cancer cells and effect of brefeldin-A on the resistant cell line. Pancreas 27:220–4.
   PubMed Web of Science ®Google Scholar
• Wang F, Yuan J, Zhang Q, et al. (2018). PTX-loaded three-layer PLGA/CS/ALG nanoparticle based on layer-by-layer method for cancer therapy. J Biomater Sci Polym Ed 29:1566–78.
   PubMed Web of Science ®Google Scholar
• Westphal M, Ram Z, Riddle V, et al. (2006). Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir 148:269–75.
   PubMed Web of Science ®Google Scholar
• Wu KQ, Liu JY, Lei L, et al. (2018). A stent film of paclitaxel presenting extreme accumulation of paclitaxel in tumor tissue and excellent antitumor efficacy after implantation beneath the subcutaneous tumor xenograft in mice. Int J Pharm 553:29–36.
   PubMed Web of Science ®Google Scholar
• Yi HG, Choi YJ, Kang KS, et al. (2016). A 3D-printed local drug delivery patch for pancreatic cancer growth suppression. J Control Release 238:231–41.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhang CJ, Liu JJ, et al. (2012). A phase II trial of Zoladex combined with CEF chemotherapy as neoadjuvant therapy in premenopausal women with hormone-responsive, operable breast cancer. Med Oncol 29:479–85.
   PubMed Web of Science ®Google Scholar